Pubblicazioni diatechadm 2018-11-14T10:51:50+00:00

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

2906, 2020

Marco Mammana et. al., Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis

806, 2020

Claudia Rengucci et. al., Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

2505, 2020

Alberto Pavan et. al., Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.

1605, 2020

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

1505, 2020

Ilaria Proietti et. al., A rare BRAF V600E mutation detected by next-generation sequencing in a superficial spreading melanoma: case report and potential diagnostic implications

705, 2020

Elisabetta Zulato et. al., Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

605, 2020

Girolamo Crisi et. al., Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach

2304, 2020

Dario de Biase et. al., Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel.

303, 2020

Özlem Aydemir et. al., Servikal örneklerde human papillomavirüs pozitifli?i ve genotip da??l?m?

2102, 2020

Deborah Cosentini et al., Activity and safety of temozolomide in advanced adrenocortical carcinoma patients with disease progression to standard chemotherapy plus mitotane

101, 2020

Florencia W Djigma et. al., Molecular Genotyping of Human Papillomavirus among HIV-infected and HIV-uninfected Women in Ouagadougou, Burkina Faso.

1612, 2019

M.Lucia Reale et. al., Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients

Previous 1 2 3 4 Next